106 related articles for article (PubMed ID: 10329371)
21. A chemically modified preparation of alpha2-macroglobulin binds beta-amyloid peptide with increased affinity and inhibits Abeta cytotoxicity.
Mettenburg JM; Arandjelovic S; Gonias SL
J Neurochem; 2005 Apr; 93(1):53-62. PubMed ID: 15773905
[TBL] [Abstract][Full Text] [Related]
22. C4b-binding protein in Alzheimer's disease: binding to Abeta1-42 and to dead cells.
Trouw LA; Nielsen HM; Minthon L; Londos E; Landberg G; Veerhuis R; Janciauskiene S; Blom AM
Mol Immunol; 2008 Aug; 45(13):3649-60. PubMed ID: 18556068
[TBL] [Abstract][Full Text] [Related]
23. Two-site binding of beta-cyclodextrin to the Alzheimer Abeta(1-40) peptide measured with combined PFG-NMR diffusion and induced chemical shifts.
Danielsson J; Jarvet J; Damberg P; Gräslund A
Biochemistry; 2004 May; 43(20):6261-9. PubMed ID: 15147210
[TBL] [Abstract][Full Text] [Related]
24. Interaction with amyloid beta peptide compromises the lipid binding function of apolipoprotein E.
Tamamizu-Kato S; Cohen JK; Drake CB; Kosaraju MG; Drury J; Narayanaswami V
Biochemistry; 2008 May; 47(18):5225-34. PubMed ID: 18407659
[TBL] [Abstract][Full Text] [Related]
25. Dynamics of Abeta turnover and deposition in different beta-amyloid precursor protein transgenic mouse models following gamma-secretase inhibition.
Abramowski D; Wiederhold KH; Furrer U; Jaton AL; Neuenschwander A; Runser MJ; Danner S; Reichwald J; Ammaturo D; Staab D; Stoeckli M; Rueeger H; Neumann U; Staufenbiel M
J Pharmacol Exp Ther; 2008 Nov; 327(2):411-24. PubMed ID: 18687920
[TBL] [Abstract][Full Text] [Related]
26. A method for evaluating the level of soluble β-amyloid(1-40/1-42) in Alzheimer's disease based on the binding of gelsolin to β-amyloid peptides.
Yu Y; Zhang L; Li C; Sun X; Tang D; Shi G
Angew Chem Int Ed Engl; 2014 Nov; 53(47):12832-5. PubMed ID: 25244702
[TBL] [Abstract][Full Text] [Related]
27. Cerebral amyloid angiopathy and dementia.
Tian J; Shi J; Mann DM
Panminerva Med; 2004 Dec; 46(4):253-64. PubMed ID: 15876981
[TBL] [Abstract][Full Text] [Related]
28. Amyloid-beta(1-42) rapidly forms protofibrils and oligomers by distinct pathways in low concentrations of sodium dodecylsulfate.
Rangachari V; Moore BD; Reed DK; Sonoda LK; Bridges AW; Conboy E; Hartigan D; Rosenberry TL
Biochemistry; 2007 Oct; 46(43):12451-62. PubMed ID: 17910477
[TBL] [Abstract][Full Text] [Related]
29. Ex situ atomic force microscopy analysis of beta-amyloid self-assembly and deposition on a synthetic template.
Ha C; Park CB
Langmuir; 2006 Aug; 22(16):6977-85. PubMed ID: 16863248
[TBL] [Abstract][Full Text] [Related]
30. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA
Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of cytotoxicity and amyloid fibril formation by a D-amino acid peptide that specifically binds to Alzheimer's disease amyloid peptide.
Wiesehan K; Stöhr J; Nagel-Steger L; van Groen T; Riesner D; Willbold D
Protein Eng Des Sel; 2008 Apr; 21(4):241-6. PubMed ID: 18252750
[TBL] [Abstract][Full Text] [Related]
32. Gelsolin inhibits the fibrillization of amyloid beta-protein, and also defibrillizes its preformed fibrils.
Ray I; Chauhan A; Wegiel J; Chauhan VP
Brain Res; 2000 Jan; 853(2):344-51. PubMed ID: 10640633
[TBL] [Abstract][Full Text] [Related]
33. Solution structures in aqueous SDS micelles of two amyloid beta peptides of A beta(1-28) mutated at the alpha-secretase cleavage site (K16E, K16F).
Poulsen SA; Watson AA; Fairlie DP; Craik DJ
J Struct Biol; 2000 Jun; 130(2-3):142-52. PubMed ID: 10940222
[TBL] [Abstract][Full Text] [Related]
34. Ca2+ binding protects against gelsolin amyloidosis.
Page LJ; Huff ME; Kelly JW; Balch WE
Biochem Biophys Res Commun; 2004 Oct; 322(4):1105-10. PubMed ID: 15336957
[TBL] [Abstract][Full Text] [Related]
35. Influence of lipoproteins on microglial degradation of Alzheimer's amyloid beta-protein.
Cole GM; Ard MD
Microsc Res Tech; 2000 Aug; 50(4):316-24. PubMed ID: 10936886
[TBL] [Abstract][Full Text] [Related]
36. Human metallothioneins 2 and 3 differentially affect amyloid-beta binding by transthyretin.
Martinho A; Gonçalves I; Cardoso I; Almeida MR; Quintela T; Saraiva MJ; Santos CR
FEBS J; 2010 Aug; 277(16):3427-36. PubMed ID: 20646067
[TBL] [Abstract][Full Text] [Related]
37. Identification of the circulating amyloid precursor and other gelsolin metabolites in patients with G654A mutation in the gelsolin gene (Finnish familial amyloidosis): pathogenetic and diagnostic implications.
Maury CP; Sletten K; Totty N; Kangas H; Liljeström M
Lab Invest; 1997 Oct; 77(4):299-304. PubMed ID: 9354764
[TBL] [Abstract][Full Text] [Related]
38. Human plasma gelsolin binds to fibronectin.
Lind SE; Janmey PA
J Biol Chem; 1984 Nov; 259(21):13262-6. PubMed ID: 6092370
[TBL] [Abstract][Full Text] [Related]
39. Interaction of amyloid beta-protein with anionic phospholipids: possible involvement of Lys28 and C-terminus aliphatic amino acids.
Chauhan A; Ray I; Chauhan VP
Neurochem Res; 2000 Mar; 25(3):423-9. PubMed ID: 10761989
[TBL] [Abstract][Full Text] [Related]
40. Gelsolin concentration in cerebrospinal fluid from patients with multiple sclerosis and other neurological disorders.
Kulakowska A; Drozdowski W; Sadzynski A; Bucki R; Janmey PA
Eur J Neurol; 2008 Jun; 15(6):584-8. PubMed ID: 18474076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
